TNFRSF6B and TNFRSF14 genes were recently associated with Crohn's disease and rheumatoid arthritis. TNFRSF14 is known as herpes virus entry mediator (HVEM), and herpes viruses have been involved in the aetiology of multiple sclerosis (MS). MS patients present human herpes virus 6 (HHV6) in active plaques and increased antibody responses to HHV6. We aimed to ascertain the role of these genes in MS susceptibility and to investigate the relationship of the gene encoding the widely expressed HVEM receptor with the active replication of HHV6 found in some MS patients. Genotyping of 1370 Spanish MS patients and 1715 ethnically matched controls was performed. HHV6A DNA levels (surrogate of active viral replication) were analysed in serum of MS patients during a 2-year follow-up. Both polymorphisms were associated with MS predisposition, with stronger effect in patients with HHV6 active replication-TNFRSF6B-rs4809330*A: P ¼ 0.028, OR ¼ 1.13; TNFRSF14-rs6684865*A: overall P ¼ 0.0008, OR ¼ 1.2; and HHV6-positive patients vs controls: P ¼ 0.017, OR ¼ 1.69.
Introduction
The activation of T lymphocytes is critically dependant on positive and negative signals to limit pathogen invasion while preventing the attack to the host. The balance of co-stimulatory and co-inhibitory secondary signals determines the quality and magnitude of the immune response. T-cell receptor engagement without costimulation leads to suboptimal T-cell activation and T-cell anergy. Two main superfamilies of co-signalling molecules based on their structure modulate the T-cell response: the immunoglobulin superfamily and the tumour necrosis factor receptor superfamily (TNFRSF). 1 One of these TNFRSF members is HVEM (herpes virus entry mediator or TNFRSF14), a molecular switch that regulates the host immune response depending on which ligand it binds. The costimulatory ligand LIGHT (lymphotoxin-like, exhibits inducible expression and competes with herpes simplex virus glycoprotein D for HVEM, a receptor expressed by T lymphocytes) is shared by another member of the TNFRSF, DcR3 (decoy receptor 3 or TNFRSF6B). Polymorphisms in proximity to the genes encoding these members of the TNFRSF, TNFRSF6B and TNFRSF14, have been recently found associated with two different autoimmune diseases, Crohn's disease and rheumatoid arthritis.
Kugathasan et al. 2 considered the TNFRSF6B gene as the most compelling candidate associated with pediatriconset inflammatory bowel disease within the linkage disequilibrium (LD) block at 20q13. The mRNA expression of this gene was markedly different in colonic biopsies of individuals with inflammatory bowel disease compared with disease-free controls and the concentration of serum DcR3 was significantly different between inflammatory bowel disease patients with and without the identified TNFRSF6B at-risk allele. These results were concordant with previous reports dealing with the high expression of DcR3 in T cells from inflamed mucosa of ulcerative colitis patients 3 or in acutely inflamed intestinal epithelia 4 The genome-wide association study (GWAS) performed by the Wellcome Trust Case-Control Consortium in 2007 5 identified a polymorphism (rs6684865) located in the MMEL1 gene adjacent to TNFRSF14, associated with rheumatoid arthritis risk. A perfect proxy located at 60 kb from TNFRSF14 in 1p36 (rs3890745, r 2 ¼ 1) was found associated with rheumatoid arthritis by metaanalyses of two genome-wide studies; 6 the role of this gene in disease risk was also validated by a study of a strongly correlated variant (rs10910099, r 2 ¼ 0.96) in an independent cohort. 7 The TNFRSF14 gene is also known as herpes virus entry mediator (HVEM), and human herpes viruses have often been involved in the aetiology of multiple sclerosis (MS). 8 The entry of viruses into cells is a complex process, which is still incompletely understood. It appears to require not only a cellular receptor (CD46) to interact with the virus attachment protein, 9 but also additional molecule(s) to facilitate penetration. 10, 11 Human herpes virus 6 (HHV6) was found in active MS plaques and increased serum antibody responses to HHV6-early antigen were demonstrated in relapsingremitting MS patients. 12, 13 Another protein playing an important role for intercellular adhesion and entry of neurotropic viruses to the brain is encoded by the herpes virus entry mediator B (HVEB) gene, which was associated with differences in the severity of MS. 14, 15 On this basis, we pursued to investigate the relationship of the gene encoding the widely expressed HVEM receptor with the active replication of HHV6 found in some MS patients.
Growing evidence exists about the shared genetic association among several autoimmune diseases, [16] [17] [18] providing insight into common aetiologic pathways. However, the dissection of the complex genetics that underlies the various autoimmune phenotypes is still in course. The mentioned members of the TNFRSF, both TNFRSF14 and TNFRSF6B, contribute to achieve an immune balance by controlling T-cell activation. Our purpose with the present study was the evaluation of the role of these two genes in the predisposition to another immune-mediated disease, MS. Given their strong LD, we aimed at studying one of the two non-coding variants on 20q13 with effect in inflammatory bowel disease predisposition (rs2315008 and rs4809330, r 2 ¼ 1; OR ¼ 0.74) and also one of the three polymorphisms previously associated with rheumatoid arthritis in the TNFRSF14 locus (rs6684865, rs10910099, and rs3890745; OR ¼ 0.89).
Results and discussion
As shown in Table 1 , polymorphisms related with both genes, TNFRSF14 and TNFRSF6B, conformed to HardyWeinberg expectations and they were associated with MS risk. The frequencies of the common allele and common genotype of rs6684865 were significantly higher in MS patients than in healthy controls. For rs4809330, the frequencies of either the minor allele or the carriers of this minor allele predisposed towards MS. TNFRSF14 shows an effect in MS similar to the one previously observed in arthritis; however, the association of TNFRSF6B with MS risk seems to display an opposite effect to the protective role originally described in Crohn's disease. A similar scenario has been recently reported for the association of CD40 C/T À1 , showing predisposition towards rheumatoid arthritis and Graves' disease, but being protective in MS. 19 Moreover, TNFRSF14 expression significantly changed in systemic lupus erythematosus patients, 20 highlighting the pleiotropic spectrum of this risk factor.
In order to further support these two loci as risk factors for MS, we looked for single-nucleotide polymorphisms (SNPs) genotyped in the GWAS performed by the International Multiple Sclerosis Genetic Consortium (IMSGC) 21 and the Wellcome Trust Case-Control Consortium, 22 which could be in high LD with rs6684865 and rs4809330 analysed in this work. In the Wellcome Trust Case-Control Consortium study, two polymorphisms of the TNFRSF14 gene exhibited significant association with MS (albeit not exceeding GWAS threshold): an Ile/Val variant at exon 7, rs2234167 (P ¼ 0.04; OR (95% CI) ¼ 1.17 (1.01-1.38)) and a Thr/Met variant located at exon 16 of the adjacent MMEL1 gene, rs3748816 (P ¼ 0.001; OR (95% CI) ¼ 0.82 (0.73-0.93)), which was in almost total LD with rs6684865 (r 2 ¼ 0.92). Therefore, these data are in agreement with the association found in our cohorts.
In the IMSGC study, no SNP could be considered as a proxy of rs6684865 or rs4809330; however, several variants were in LD with these SNPs (D 0 ¼ 1 and r 2 p0.57). As it has been reported that analyses using haplotypes of multiple tightly linked markers are usually more informative than those using a single marker, 23, 24 we decided to perform multimarker transmission disequilibrium tests in the TNFRSF14 and TNFRSF6B loci with 931 family trios from the IMSGC GWAS data (Supplementary Figure 1 and Supplementary Tables 1 32, 33 Genotyping of the samples was carried out with predesigned TaqMan Assays from Applied Biosystems (Applied Biosystems, Foster City, CA, USA). Genotyping call-rate success was over 98% in MS cases and controls for both tested polymorphisms. Chi-square test or Fisher's exact test (when expected values were below 5) performed by a standard statistical package (Epi Info v. 5; World Health Organization, Geneva, Switzerland). and 2). For each locus, we tested the statistical significance of the most common haplotype among the transmitted set. In both loci, the hapolypes windows bearing the SNPs in higher LD with rs6684865 and rs4809330 showed the lowest P-values. Therefore, the haplotype analysis also supports that both regions are risk loci for MS.
Given that the TNFRSF14 gene encodes a herpes virus entry mediator, and herpes virus has been involved in the aetiology of several autoimmune diseases, such as rheumatoid arthritis and MS, we decided to investigate the influence of this gene on the presence of HHV6A DNA levels in serum of MS patients, a surrogate of active viral replication. This analysis suggested the different distribution of the observed risk genotype AA of rs6684865 between MS patients with (63%) and without (45%) active replication of the virus (Table 2) . Interestingly, the frequency of the risk genotype in the virus-free group was similar to that one present in controls (46%), whereas the HHV6-positive group clearly departed from controls. The overall allelic difference between HHV6-positive and HHV6-negative groups evidenced statistical significance (A allele: 93/120 vs 177/268, P ¼ 0.02). The comparison of the HHV6-positive patients (Table 2 ) with controls (Table 1) yielded a more intense effect of the risk allele (OR ¼ 1.69) than the one observed when the global MS cohort was considered (OR ¼ 1.2).
HHV6 is one of the strongest environmental candidates for an association with MS, supported by the presence of anti-HHV6 antibodies in MS cerebrospinal fluid and the detection of viral DNA in cerebrospinal fluid and plaques. [25] [26] [27] Increased prevalence of HHV6 DNA levels in serum 28, 29 and RNA/DNA levels in peripheral blood mononuclear cells 30 have been associated with exacerbations in relapsing-remitting MS. A cellular receptor for HHV6 is the complement regulatory protein CD46; 9 however, as already mentioned, all the molecular players involved in viral entry may not be described yet. Therefore, one of those entry helpers could be encoded by the TNFRSF14 gene and, as shown by the present data, a polymorphism, which was previously associated with rheumatoid arthritis susceptibility has also demonstrated its role in MS predisposition and in HHV6 active replication, as measured by viral DNA levels in serum. The 2-year follow-up allowed the confident ascertainment of HHV6-positive and HHV6-negative individuals. This longitudinal study yielded suggestive results that need to be corroborated in an independent set of data and evidenced a particular strong effect of the TNFRSF14 gene in the group of patients showing HHV6 active replication.
Genetics and environment act together to induce MS and other forms of complex diseases. The ascertainment of the factors involved in predisposition towards a specific disease will aid in the understanding of its aetiology and will ultimately contribute to the development of new therapies and lead to a more personalised treatment.
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